The U.S. Navy’s Pacific Command Headquarters in Hawaii is the second important naval base to deploy biometric readers from Bioscrypt and contactless smart cards from HID. The system is designed to help further secure areas of sensitive access adding the fingerprint biometric to card and PIN requirements.
U.S. Pacific Command Headquarters Selects Bioscrypt V-Smart iClass Finger Scan Reader for Biometric Trials
SPAWAR Leads Installation Aimed at Determining Suitability for Future Generations of the Common Access Card at Navy Region Hawaii and Throughout Pacific Region
TORONTO, Sept. 14 /PRNewswire-FirstCall/ – Bioscrypt Inc. (TSX: BYT), a leading provider of identity verification technology, today announced that Space and Naval Warfare Systems Activity Pacific has chosen Bioscrypt’s V-Smart iClass biometric access control reader to augment physical access control at Pacific Command Headquarters (PACOM), and to analyze the benefits of implementing biometric contactless technologies for future generations of the Common Access Card (CAC) at Navy Region Hawaii and other Naval installations throughout the Pacific region.
Biometric readers are used to provide access control to Secure Compartmented Information Facilities (SCIFs) and other sensitive areas within PACOM’s new headquarters facility HQ21 at Camp H.M. Smith, Hawaii.
Brian Maxwell, SPAWAR Security Systems Specialist stated, “We chose biometrics to increase the certainty that only an authorized person can access a classified space as compared to using a card and pin alone.”
“It is vital that Navy Region Hawaii retain the most advance security measure available,” stated Capt. Ronald R. Cox, Commander, Navy Region Hawaii (Acting)/Chief of Staff/Commanding Officer, Naval Station Pearl Harbor. “Biometrics is leading edge technology providing the greatest level of verification obtainable.”
“We are pleased that the US Pacific Command headquarters is the second base to successfully complete trials of our technology to determine suitability for the common access card,” said Pierre Donaldson, President and CEO, Bioscrypt. “In many instances independent testing of our technology continues to be performed in advance of full implementation. We remain confident that as more trials indicate our technology exceeds requirements set out by the most demanding situations the more confident future users will be in adopting it.”